Blocking type 2 inflammation by dupilumab does not control classic (type 1‐driven) allergic contact dermatitis in chronic hand eczema. (10th April 2019) - Crepy, Marie‐Noëlle; Nosbaum, Audrey; Bensefa‐Colas, Lynda